Literature DB >> 11179110

Tumor necrosis factor-alpha -308 promoter gene polymorphism and increased tumor necrosis factor serum bioactivity in farmer's lung patients.

B M Schaaf1, U Seitzer, V Pravica, S P Aries, P Zabel.   

Abstract

Hypersensitivity pneumonitis (HP) represents an immunologic reaction of the pulmonary parenchyma to an inhaled agent. Since tumor necrosis factor (TNF)-alpha is thought to be involved in the pathogenesis of HP, and polymorphisms in the TNF genes have been associated with variations in the production of TNF-alpha, we investigated the serum bioactivity and genotype of TNF in HP. TNF bioactivity was measured after hay dust challenge in eight patients with farmer's lung (Group A) and in 12 healthy, sensitized (antibody-positive) controls (Group B). Genotyping for the -308 TNF-alpha promoter polymorphism and the TNF-beta intron 1 gene polymorphism was performed in 20 patients with farmer's lung, 25 patients with pigeon breeder's lung, and 216 controls. TNF bioactivity increased in Group A at 4 to 10 h after hay dust challenge, but not in Group B (p < 0.05). The frequency for the TNFA2 allele, a genotype associated with high TNF-alpha production in vitro, was significantly higher in farmer's lung patients (frequency [f] = 0.43, p = 0.0012) than in controls (f = 0.19) or patients with pigeon breeder's lung (f = 0.16). Genotyping for TNF-beta revealed no significant abnormalities. Thus, increased production of TNF-alpha after hay contact, and a genetic predisposition to TNF-alpha production, are implicated in the pathogenesis of alveolitis in farmer's lung.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11179110     DOI: 10.1164/ajrccm.163.2.2002062

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  12 in total

1.  The shared epitope is a marker of severity associated with selection for, but not with response to, infliximab in a large rheumatoid arthritis population.

Authors:  H Marotte; B Pallot-Prades; L Grange; J Tebib; P Gaudin; C Alexandre; J L Blond; M A Cazalis; B Mougin; P Miossec
Journal:  Ann Rheum Dis       Date:  2005-08-11       Impact factor: 19.103

Review 2.  Takes your breath away--the immunology of allergic alveolitis.

Authors:  C McSharry; K Anderson; S J Bourke; G Boyd
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

3.  S1P1 Contributes to Endotoxin-enhanced B-Cell Functions Involved in Hypersensitivity Pneumonitis.

Authors:  Carole-Ann Huppé; Pascale Blais-Lecours; Emilie Bernatchez; Jean-François Lauzon-Joset; Caroline Duchaine; Hugh Rosen; Geneviève Dion; Kelly M McNagny; Marie-Renée Blanchet; Mathieu C Morissette; David Marsolais
Journal:  Am J Respir Cell Mol Biol       Date:  2020-08       Impact factor: 6.914

Review 4.  Clinical parameters and biomarkers for anti-TNF treatment prognosis in rheumatoid arthritis patients.

Authors:  Miguel Cuchacovich; Daniel Bueno; Rodrigo Carvajal; Nicolás Bravo; Juan Carlos Aguillón; Diego Catalán; Lilian Soto
Journal:  Clin Rheumatol       Date:  2014-08-02       Impact factor: 2.980

5.  Genetic variability of T cell responses in hypersensitivity pneumonitis identified using the BXD genetic reference panel.

Authors:  Jin Wang; Tae Won Yoon; Robert Read; Ae-Kyung Yi; Robert W Williams; Elizabeth A Fitzpatrick
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2020-01-15       Impact factor: 5.464

Review 6.  The role of genetic polymorphisms in environmental health.

Authors:  Samir N Kelada; David L Eaton; Sophia S Wang; Nathaniel R Rothman; Muin J Khoury
Journal:  Environ Health Perspect       Date:  2003-06       Impact factor: 9.031

Review 7.  Genetic polymorphisms in lung disease: bandwagon or breakthrough?

Authors:  Michael C Iannuzzi; Mary Maliarik; Benjamin Rybicki
Journal:  Respir Res       Date:  2002-02-19

Review 8.  Surfactant gene polymorphisms and interstitial lung diseases.

Authors:  Panagiotis Pantelidis; Srihari Veeraraghavan; Roland M du Bois
Journal:  Respir Res       Date:  2001-11-29

9.  Increased mortality in septic shock with the 4G/4G genotype of plasminogen activator inhibitor 1 in patients of white descent.

Authors:  Gloria García-Segarra; Gerard Espinosa; Dolors Tassies; Josep Oriola; Jesús Aibar; Albert Bové; Pedro Castro; Joan-Carles Reverter; Josep-Maria Nicolás
Journal:  Intensive Care Med       Date:  2007-05-31       Impact factor: 41.787

10.  Tumour necrosis factor (TNF)-α-308 gene polymorphism in Indian patients with Takayasu's arteritis - a pilot study.

Authors:  P Sandhya; Sumita Danda; Debashish Danda; Shraddha Lonarkar; Shana S Luke; Shanta Sinha; George Joseph
Journal:  Indian J Med Res       Date:  2013-04       Impact factor: 2.375

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.